Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2023-10-11
DOI
10.1080/14787210.2023.2270160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergy and Mechanism of Leflunomide Plus Fluconazole Against Resistant Candida albicans: An in vitro Study
- (2023) Xiuyun Li et al. Infection and Drug Resistance
- The Impact of COVID-19 on the Epidemiology and Outcomes of Candidemia: A Retrospective Study from a Tertiary Care Center in Lebanon
- (2023) Aline El Zakhem et al. Journal of Fungi
- Synergistic Effects of Fluconazole Combined with Doxycycline Against Dual-Species Cultures of Candida albicans and Staphylococcus epidermidis and the Mechanisms of Action
- (2022) Yuan Gao et al. Microbial Drug Resistance
- Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era
- (2022) Christina Routsi et al. Antibiotics-Basel
- Fructose Induces Fluconazole Resistance in Candida albicans through Activation of Mdr1 and Cdr1 Transporters
- (2021) Jakub Suchodolski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Kinome analyses of Candida albicans, C. parapsilosis and C. tropicalis enable novel kinases as therapeutic drug targets in candidiasis
- (2021) Sanjib Das et al. GENE
- Lactoferrin is broadly active against yeasts and highly synergistic with amphotericin B
- (2020) Kenya E. Fernandes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Eravacycline: A Novel Fluorocycline
- (2020) Sara Alosaimy et al. PHARMACOTHERAPY
- In Vitro and In Vivo Study on the Synergistic Effect of Minocycline and Azoles against Pathogenic Fungi
- (2020) Lujuan Gao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
- (2020) Morgan A Wambaugh et al. eLife
- Synergistic Effects and Mechanisms of Combined Treatment With Harmine Hydrochloride and Azoles for Resistant Candida albicans
- (2019) Xiuyun Li et al. Frontiers in Microbiology
- Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis
- (2018) Kimberley A. Savage et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development and regulation of single- and multi-species Candida albicans biofilms
- (2017) Matthew B. Lohse et al. NATURE REVIEWS MICROBIOLOGY
- Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study
- (2016) Laurent Tadec et al. MYCOSES
- NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning
- (2016) Xing Chen et al. PLoS Computational Biology
- In vitro interactions between fluconazole and minocycline against mixed cultures of Candida albicans and Staphylococcus aureus
- (2015) Hui Li et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Morphogenesis checkpoint kinase Swe1 is the executor of lipolysis-dependent cell-cycle progression
- (2015) Neha Chauhan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA Enrichment Method for Quantitative Transcriptional Analysis of Pathogens In Vivo Applied to the Fungus Candida albicans
- (2015) Sara Amorim-Vaz et al. mBio
- Cryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonella
- (2014) Nuria Trevijano-Contador et al. Virulence
- Candida albicans, plasticity and pathogenesis
- (2013) Daniel Poulain CRITICAL REVIEWS IN MICROBIOLOGY
- The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents
- (2010) Wenna Shi et al. FEMS YEAST RESEARCH
- In vitro activity of antifungal combinations against Candida albicans biofilms
- (2009) S. Tobudic et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Time Course Global Gene Expression Analysis of an In VivoCandidaBiofilm
- (2009) Jeniel E. Nett et al. JOURNAL OF INFECTIOUS DISEASES
- SLA2 mutations cause SWE1-mediated cell cycle phenotypes in Candida albicans and Saccharomyces cerevisiae
- (2009) C. A. Gale et al. MICROBIOLOGY-SGM
- Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans
- (2009) Montserrat Martínez-Gomariz et al. PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started